Abstract
Orlistat (Alli; Xenical), which inhibits gastric and pancreatic lipase and prevents some dietary fat absorption, is one of only a few drugs available for treating obesity. In 2009, the FDA issued a warning about possible association between orlistat use and liver injury. In this population-based study, U.K. investigators used several large databases to …
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
